These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 9620920)

  • 41. Revised Antituberculosis Drug Doses and Hepatotoxicity in HIV Negative Children.
    Indumathi CK; Sethuraman A; Jain S; Krishnamurthy S
    Indian J Pediatr; 2019 Mar; 86(3):229-232. PubMed ID: 30515702
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An official ATS statement: hepatotoxicity of antituberculosis therapy.
    Saukkonen JJ; Cohn DL; Jasmer RM; Schenker S; Jereb JA; Nolan CM; Peloquin CA; Gordin FM; Nunes D; Strader DB; Bernardo J; Venkataramanan R; Sterling TR;
    Am J Respir Crit Care Med; 2006 Oct; 174(8):935-52. PubMed ID: 17021358
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incidence of and risk factors for severe liver toxicity in HIV-infected patients on anti-tuberculosis treatment.
    Pukenyte E; Lescure FX; Rey D; Rabaud C; Hoen B; Chavanet P; Laiskonis AP; Schmit JL; May T; Mouton Y; Yazdanpanah Y
    Int J Tuberc Lung Dis; 2007 Jan; 11(1):78-84. PubMed ID: 17217134
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatotoxicity due to antituberculosis therapy. Clinical profile and reintroduction of therapy.
    Singh J; Garg PK; Tandon RK
    J Clin Gastroenterol; 1996 Apr; 22(3):211-4. PubMed ID: 8724260
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antituberculous drug-induced liver injury: current perspective.
    Devarbhavi H
    Trop Gastroenterol; 2011; 32(3):167-74. PubMed ID: 22332331
    [TBL] [Abstract][Full Text] [Related]  

  • 46. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Short communication: antituberculosis drug-induced hepatotoxicity is unexpectedly low in HIV-infected pulmonary tuberculosis patients in Malawi.
    Tostmann A; Boeree MJ; Harries AD; Sauvageot D; Banda HT; Zijlstra EE
    Trop Med Int Health; 2007 Jul; 12(7):852-5. PubMed ID: 17596252
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incidence of hepatotoxicity due to antitubercular medicines and assessment of risk factors.
    Shakya R; Rao BS; Shrestha B
    Ann Pharmacother; 2004 Jun; 38(6):1074-9. PubMed ID: 15122004
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence, risk factors, management, and treatment outcomes of first-line antituberculous drug-induced liver injury: a prospective cohort study.
    Sun Q; Zhang Q; Gu J; Sun WW; Wang P; Bai C; Xiao HP; Sha W
    Pharmacoepidemiol Drug Saf; 2016 Aug; 25(8):908-17. PubMed ID: 26935778
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Side effects due to primary antituberculosis drugs during the initial phase of therapy in 1149 hospitalized patients for tuberculosis.
    Gülbay BE; Gürkan OU; Yildiz OA; Onen ZP; Erkekol FO; Baççioğlu A; Acican T
    Respir Med; 2006 Oct; 100(10):1834-42. PubMed ID: 16517138
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk factors for hepatotoxicity from antituberculosis drugs: a case-control study.
    Pande JN; Singh SP; Khilnani GC; Khilnani S; Tandon RK
    Thorax; 1996 Feb; 51(2):132-6. PubMed ID: 8711642
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Monitoring and management of antituberculosis drug induced hepatotoxicity.
    Agal S; Baijal R; Pramanik S; Patel N; Gupte P; Kamani P; Amarapurkar D
    J Gastroenterol Hepatol; 2005 Nov; 20(11):1745-52. PubMed ID: 16246196
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users.
    Roux P; Fugon L; Winnock M; Salmon-Céron D; Lacombe K; Sogni P; Spire B; Dabis F; Carrieri MP;
    Addiction; 2012 Jan; 107(1):152-9. PubMed ID: 21819472
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Isoniazid preventive therapy, hepatitis C virus infection, and hepatotoxicity among injection drug users infected with Mycobacterium tuberculosis.
    Sadaphal P; Astemborski J; Graham NM; Sheely L; Bonds M; Madison A; Vlahov D; Thomas DL; Sterling TR
    Clin Infect Dis; 2001 Nov; 33(10):1687-91. PubMed ID: 11641824
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The efficacy of Jujube syrup on the prevention of drug-induced hepatotoxicity in pulmonary tuberculosis patients: A pilot randomized double-blind placebo-controlled clinical trial.
    Maddahi SZ; Jokar A; Kamalinejad M; Behnampur N
    Pharmacol Res Perspect; 2022 Feb; 10(1):e00902. PubMed ID: 34939363
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antituberculosis drug-induced liver injury in chronic hepatitis and cirrhosis.
    Park WB; Kim W; Lee KL; Yim JJ; Kim M; Jung YJ; Kim NJ; Kim DH; Kim YJ; Yoon JH; Oh MD; Lee HS
    J Infect; 2010 Oct; 61(4):323-9. PubMed ID: 20670648
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Hepatotoxicity caused by antituberculosis drugs in pediatrics].
    Reto Valiente LV; Castillo Vergara J; Pichilingue Reto P; Pichilingue Prieto OA
    Rev Gastroenterol Peru; 2005; 25(4):362-5. PubMed ID: 16333392
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The treatment of chronic hepatitis C with interferon in patients infected with the human immunodeficiency virus. The Spanish Group for the Study of Viral Hepatitis in HIV+ Patients].
    Soriano V; García-Samaniego J; Bravo R; González J; Castro A; Martńez-Odriozola P; Colmenero M; Carballo E; Suárez D; Castilla J; Rodriguez-Piñero FJ; Moreno A; del Romero J; Pedreira J; González-Lahoz J
    Med Clin (Barc); 1996 Apr; 106(13):486-90. PubMed ID: 8992129
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatotoxicity to different antituberculosis drug combinations.
    Aziz S; Agha F; Hassan R; Fairoz SA; Hassan K
    J Pak Med Assoc; 1990 Dec; 40(12):290-4. PubMed ID: 2126569
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The influence of human immunodeficiency virus infection on tuberculosis in Kampala, Uganda.
    Eriki PP; Okwera A; Aisu T; Morrissey AB; Ellner JJ; Daniel TM
    Am Rev Respir Dis; 1991 Jan; 143(1):185-7. PubMed ID: 1986677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.